Ultrasonographic Evaluation of Three Approaches for Botulinum Toxin Injection into Tibialis Posterior Muscle in Chronic Stroke Patients with Equinovarus Foot: An Observational Study

Spastic equinovarus (SEV) foot deformity is commonly observed in patients with post-stroke spasticity. Tibialis posterior (TP) is a common target for botulinum toxin type-A (BoNT-A) injection, as a first-line treatment in non-fixed SEV deformity. For this deep muscle, ultrasonographic guidance is cr...

Full description

Bibliographic Details
Published in:	Toxins
Main Authors:	Stefania Spina, Salvatore Facciorusso, Chiara Botticelli, Domenico Intiso, Maurizio Ranieri, Antonio Colamaria, Pietro Fiore, Chiara Ciritella, François Genêt, Andrea Santamato
Format:	Article
Language:	English
Published:	MDPI AG 2021-11-01
Subjects:	BoNT-A ultrasound-guided injection spastic equinovarus foot tibialis posterior muscle stroke
Online Access:	https://www.mdpi.com/2072-6651/13/11/829

Similar Items

The Role of Botulinum Toxin Type-A in Spasticity: Research Trends from a Bibliometric Analysis
by: Salvatore Facciorusso, et al.
Published: (2024-04-01)

Botulinum neurotoxin X lacks potency in mice and in human neurons
by: Brieana M. Gregg, et al.
Published: (2024-03-01)

Use of Botulinum Toxin in the Treatment of Patients with Upper Limb Spasticity After Stroke – a Systematic Review
by: Małgorzata Gucwa, et al.
Published: (2025-07-01)

Detection of Active BoNT/C and D by EndoPep-MS Using MALDI Biotyper Instrument and Comparison with the Mouse Test Bioassay
by: Ilenia Drigo, et al.
Published: (2020-12-01)

Sheep Monoclonal Antibodies Prevent Systemic Effects of Botulinum Neurotoxin A1
by: Charles B. Shoemaker, et al.
Published: (2012-12-01)

Structural Analysis of Botulinum Neurotoxins Type B and E by Cryo-EM
by: Sara Košenina, et al.
Published: (2021-12-01)

Examining the role of intrinsic and reflexive contributions to ankle joint hyper-resistance treated with botulinum toxin-A
by: Ronald C. van’t Veld, et al.
Published: (2023-02-01)

Discrimination of the Activity of Low-Affinity Wild-Type and High-Affinity Mutant Recombinant BoNT/B by a SIMA Cell-Based Reporter Release Assay
by: Frank Neuschäfer-Rube, et al.
Published: (2022-01-01)

Development and Functional Characterization of Monoclonal Antibodies for Botulinum Neurotoxin Serotype A
by: Jingmei Kang, et al.
Published: (2025-05-01)

Review: Botulinum Toxin for Treatment of Focal Limb Dystonia
by: Emma H. Kaplan, et al.
Published: (2025-03-01)

Botulinum Toxin for Neuropathic Pain: A Review of the Literature
by: Hyun-Mi Oh, et al.
Published: (2015-08-01)

Pathogenicity and virulence of Clostridium botulinum
by: Alexander M. Rawson, et al.
Published: (2023-12-01)

Antibody-Integrated Solid-to-Gel Microfilm for Protection Against Botulinum Neurotoxin Type A
by: Ji-Hwan Ha, et al.
Published: (2025-09-01)

Botulinum Toxin Type A for the Treatment of Skin Ulcers: A Review Article
by: Waranaree Winayanuwattikun, et al.
Published: (2022-06-01)

Ultrasonographic Evaluation of Botulinum Toxin Injection Site for the Medial Approach to Tibialis Posterior Muscle in Chronic Stroke Patients with Spastic Equinovarus Foot: An Observational Study
by: Alessandro Picelli, et al.
Published: (2017-11-01)

Therapeutic Applications of Botulinum Neurotoxins in Veterinary Medicine
by: Lauretta Turin, et al.
Published: (2023-07-01)

Botulinum toxin in the treatment of neuralgia and neuropathic pain
by: Katarzyna Mielniczek
Published: (2021-09-01)

The Effect of Tibialis Anterior Tendon Transfer on Metatarsus Adductus Deformity in Children with Clubfoot
by: Osman Nuri Özyalvaç, et al.
Published: (2019-01-01)

The destructive effect of botulinum neurotoxins on the SNARE protein: SNAP-25 and synaptic membrane fusion
by: Bin Lu
Published: (2015-06-01)

The role of botulinum toxin in the treatment of diseases beyond aesthetics: migraine, hyperhidrosis and bruxism - literature review
by: Karolina Oskroba, et al.
Published: (2025-05-01)

Botulinum Toxin for Pain Relief in Cancer Patients: A Systematic Review of Randomized Controlled Trials
by: Lorenzo Lippi, et al.
Published: (2024-03-01)

Triceps Surae Muscle Characteristics in Spastic Hemiparetic Stroke Survivors Treated with Botulinum Toxin Type A: Clinical Implications from Ultrasonographic Evaluation
by: Marco Battaglia, et al.
Published: (2021-12-01)

Botulinum Toxin for the Treatment of Hemifacial Spasm: An Update on Clinical Studies
by: Nicola Tambasco, et al.
Published: (2021-12-01)

Development and Characterization of Monoclonal Antibodies to Botulinum Neurotoxin Type E
by: Candace S. Bever, et al.
Published: (2019-07-01)

The 25 kDa H<sub>CN</sub> Domain of Clostridial Neurotoxins Is Indispensable for Their Neurotoxicity
by: Julian Deppe, et al.
Published: (2020-11-01)

Multidimensional Effectiveness of Botulinum Toxin in Neuropathic Pain: A Systematic Review of Randomized Clinical Trials
by: Lorenzo Lippi, et al.
Published: (2022-04-01)

Tracing and characterization of foodborne botulism caused by the new MLST type Clostridium botulinum A2 in Hebei province, China
by: Ziwei Lu, et al.
Published: (2025-03-01)

Botulinum Toxin-A, Generating a Hypothesis for Orofacial Pain Therapy
by: Yair Sharav, et al.
Published: (2025-08-01)

The Relationship Between Stiff Knee Gait Runner’s Dystonia and Musculoskeletal Knee Pathology: A Case Series
by: Jared A. Stowers, et al.
Published: (2025-03-01)

High dose botox injection for treatment of high grade vesicoureteral reflux in a complicated pediatric case: A case report
by: Narjes Saberi, et al.
Published: (2025-05-01)

Recommendations for a paradigm shift in approach to increase the recognition and treatment of sialorrhea in Parkinson’s disease
by: Bruno Bergmans, et al.
Published: (2023-01-01)

Usos prácticos de la toxina botulínica en niños y adolescentes en medicina física y rehabilitación
by: S. Susana lillo, DRA., et al.
Published: (2014-03-01)

Structural and Biochemical Characterization of Botulinum Neurotoxin Subtype B2 Binding to Its Receptors
by: Jonathan R. Davies, et al.
Published: (2020-09-01)

Botulinum Toxin Type A—A Modulator of Spinal Neuron–Glia Interactions under Neuropathic Pain Conditions
by: Ewelina Rojewska, et al.
Published: (2018-04-01)

Clinical Efficacy of Bladder Neck Injection of Botulinum Toxin A in Treating Neurogenic and Non-Neurogenic Voiding Dysfunctions Due to Bladder Neck Dysfunction
by: Yu-Shuang Lee, et al.
Published: (2025-06-01)

Exploring the genetic background of the botulism neurotoxin BoNT/B2 in Spain
by: Sylvia Valdezate, et al.
Published: (2023-10-01)

Ultrasound-Guided Botulinum Toxin-A Injections into the Masseter Muscle for Both Medical and Aesthetic Purposes
by: Marius Nicolae Popescu, et al.
Published: (2024-09-01)

Botulinum neurotoxin type A in the interdisciplinary treatment of sialorrhea in adults and children—update and practice recommendations
by: Wolfgang H. Jost, et al.
Published: (2023-12-01)

Botulinum toxin A decreases neural activity in pain-related brain regions in individuals with chronic ocular pain and photophobia
by: Nicholas Reyes, et al.
Published: (2023-06-01)

Association of Long-Term Treatment by Botulinum Neurotoxins and Occupational Therapy with Subjective Physical Status in Patients with Post-Stroke Hemiplegia
by: Toyohiro Hamaguchi, et al.
Published: (2019-08-01)